Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.

The potential and applicability of UHPSFC-MS/MS for anti-doping screening in urine samples were tested for the first time. For this purpose, a group of 110 doping agents with diverse physicochemical properties was analyzed using two separation techniques, namely UHPLC-MS/MS and UHPSFC-MS/MS in both ESI+ and ESI- modes. The two approaches were compared in terms of selectivity, sensitivity, linearity and matrix effects. As expected, very diverse retentions and selectivities were obtained in UHPLC and UHPSFC, proving a good complementarity of these analytical strategies. In both conditions, acceptable peak shapes and MS detection capabilities were obtained within 7 min analysis time, enabling the application of these two methods for screening purposes. Method sensitivity was found comparable for 46% of tested compounds, while higher sensitivity was observed for 21% of tested compounds in UHPLC-MS/MS and for 32% in UHPSFC-MS/MS. The latter demonstrated a lower susceptibility to matrix effects, which were mostly observed as signal suppression. In the case of UHPLC-MS/MS, more serious matrix effects were observed, leading typically to signal enhancement and the matrix effect was also concentration dependent, i.e., more significant matrix effects occurred at the lowest concentrations.

[1]  P. Taylor Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. , 2005, Clinical biochemistry.

[2]  A. Periat,et al.  Hydrophilic interaction chromatography versus reversed phase liquid chromatography coupled to mass spectrometry: effect of electrospray ionization source geometry on sensitivity. , 2014, Journal of chromatography. A.

[3]  David A Cowan,et al.  Use of ultra-high pressure liquid chromatography coupled to high resolution mass spectrometry for fast screening in high throughput doping control. , 2013, Journal of chromatography. A.

[4]  Timothy Olah,et al.  Mechanistic investigation of ionization suppression in electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[5]  N. Day,et al.  Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[6]  Davy Guillarme,et al.  Modern analytical supercritical fluid chromatography using columns packed with sub-2 μm particles: a tutorial. , 2014, Analytica chimica acta.

[7]  Davy Guillarme,et al.  Analysis of basic compounds by supercritical fluid chromatography: attempts to improve peak shape and maintain mass spectrometry compatibility. , 2012, Journal of chromatography. A.

[8]  L. Favreau,et al.  Supercritical fluid chromatography/tandem mass spectrometric method for analysis of pharmaceutical compounds in metabolic stability samples. , 2006, Journal of pharmaceutical and biomedical analysis.

[9]  Davy Guillarme,et al.  Coupling state-of-the-art supercritical fluid chromatography and mass spectrometry: from hyphenation interface optimization to high-sensitivity analysis of pharmaceutical compounds. , 2014, Journal of chromatography. A.

[10]  K. Deventer,et al.  Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC-HRMS for doping control. , 2012, Analytica chimica acta.

[11]  M. Sandahl,et al.  Impact of injection solvents on supercritical fluid chromatography. , 2013, Journal of chromatography. A.

[12]  J. David Pinkston,et al.  Advantages and Drawbacks of Popular Supercritical Fluid Chromatography / Mass Spectrometry Interfacing Approaches—A User's Perspective , 2005 .

[13]  Y. Hsieh,et al.  Supercritical fluid chromatography-mass spectrometry for chemical analysis. , 2008, Journal of separation science.

[14]  Sherry Wang,et al.  Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. , 2007, Journal of pharmaceutical and biomedical analysis.

[15]  F. Gosetti,et al.  Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry. , 2010, Journal of chromatography. A.

[16]  K. Deventer,et al.  A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry. , 2011, Journal of chromatography. A.

[17]  Martial Saugy,et al.  Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions. , 2015, Analytica chimica acta.

[18]  Achille Cappiello,et al.  An overview of matrix effects in liquid chromatography-mass spectrometry. , 2011, Mass spectrometry reviews.

[19]  Erin Chambers,et al.  Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[20]  Jean W. Lee,et al.  Supercritical fluid chromatography-tandem mass spectrometry for fast bioanalysis of R/S-warfarin in human plasma. , 2006, Journal of pharmaceutical and biomedical analysis.

[21]  Mohammed Jemal,et al.  Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard. , 2003, Rapid communications in mass spectrometry : RCM.

[22]  L Avois,et al.  Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis. , 2009, Journal of chromatography. A.

[23]  Davy Guillarme,et al.  Comparison of ultra-high performance supercritical fluid chromatography and ultra-high performance liquid chromatography for the analysis of pharmaceutical compounds. , 2012, Journal of chromatography. A.

[24]  Monica Mazzarino,et al.  Screening and confirmation analysis of stimulants, narcotics and beta-adrenergic agents in human urine by hydrophilic interaction liquid chromatography coupled to mass spectrometry. , 2011, Journal of chromatography. A.

[25]  Timothy D Veenstra,et al.  Clinical and pharmaceutical applications of packed-column supercritical fluid chromatography. , 2008, Journal of separation science.

[26]  J. Veuthey,et al.  Maximizing kinetic performance in supercritical fluid chromatography using state-of-the-art instruments. , 2013, Journal of chromatography. A.

[27]  M. Saito,et al.  History of supercritical fluid chromatography: instrumental development. , 2013, Journal of bioscience and bioengineering.

[28]  Fangbiao Li,et al.  Supercritical fluid chromatography and high-performance liquid chromatography/tandem mass spectrometric methods for the determination of cytarabine in mouse plasma. , 2007, Analytical chemistry.

[29]  E. Fukusaki,et al.  An isotope effect on the comparative quantification of flavonoids by means of methylation-based stable isotope dilution coupled with capillary liquid chromatography/mass spectrometry. , 2005, Journal of bioscience and bioengineering.